Significant progress has been achieved in the realm of therapeutic interventions for multiple myeloma (MM), leading to transformative shifts in its clinical management. This article provides an overview of CAR-T cell therapy in Multiple Myeloma (MM), the utilization of B-cell maturation antigen (BCMA) as the target antigen, and an overview of other target moieties. https://lnkd.in/gsEejDfc
Marco Romano
10mo
Congratulations Kamal and happy new year!
Assistant Professor, Radiation Oncology, All India Institute of Medical Sciences, Delhi | MoHFW, Government of India | Author | Editor | Onco-environmentalist | Cancer Activist |
10moCongratulations sir and thank you for agreeing to work on this paper.